ArticleJournal of diabetes and metabolic disorders2020
Diagnostic validity of the pre-diabetes scale among at-risk rural Iranian adults for screening for pre-diabetes.
Article in Journal of diabetes and metabolic disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.
- A dual domain systematic review and meta-analysis of risk tool accuracy to predict cardiovascular morbidity in prehypertension and diabetic morbidity in prediabetes.Frontiers in endocrinology · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAn intense increase in pre-diabetes has taken place among the worldwide population each year. The purpose of this study was to assess the diagnostic validity of the American Diabetes Association (ADA) screening questionnaire for identifying pre-diabetes in the Iranian rural population.
methodsThis study was conducted in Ahar County, East Azarbaijan, Iran. The participants (
resultsA total of 440 adults ages 30-65 years (Mage = 48.8 years, SDage = 11.2 years) were included in the study. Around half of the participants were women (50%), illiterate (51.4%), and married (85.2). In the pre-diabetes diagnosis scale, the present cut-point yielded a sensitivity of 98.7 (95% CI:96.6-99.6), specificity of 53.1 (95% CI: 44.6-61.5), positive predictive value (PPV) of 81.4 (95% CI:77-85.3), positive predictive value (NPV) of 95.0 (95% CI:87.7-98.6), and accuracy of 83.9 (95% CI:81.4-89.2) with an area under curve (AUC) of 0.84 (95% CI: 0.80 - 0.89).
conclusionsThe Persian version of the ADA questionnaire had good sensitivity and fair specificity for pre-diabetes diagnosis among rural adults at high risk for developing type 2 diabetes. The study provided evidence for the ADA questionnaire as a valid and reliable tool for identifying pre-diabetes in a rural area. Identifying rural residents in the early stage of developing diabetes with a simple and accurate instrument without the need for a FBG test contributes to controlling the disease in areas with limited access to health services.
trial registrationThe study is not a trial; the registration number is not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.